Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
14 Diseases matching "Multiple Sclerosis"
Multiple Sclerosis
Multiple Sclerosis Lesion
Multiple Sclerosis Relapse
Multiple Sclerosis In Children
Multiple Sclerosis, Acute Relapsing
Multiple Sclerosis, Acute Fulminating
Multiple Sclerosis, Primary Progressive
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Chronic Progressive
Multiple Sclerosis, Secondary Progressive
Benign Multiple Sclerosis
Progressive Multiple Sclerosis
Opticospinal Multiple Sclerosis
Exacerbation of Multiple Sclerosis
🏥 Disease / Health Topic
Multiple Sclerosis
31
Clinical Trials
27
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00841321
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
Completed · Phase 2
NCT00276341
Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis
Completed · Phase 3
NCT02280876
Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)
Completed · Phase 1|Phase 2
📊 Sample Meta-Analyses
CRD42018105272
The incidence of adverse events of andrographis paniculata: a systematic review and meta-analysis
- Diagnoses of upper respiratory tract infections include common cold, laryngiti
CRD42020172575
Protocol for a systematic review without meta-analysis of the safety of sphingosine 1 phosphate modulators in inflammatory bowel disease and other immune-mediated diseases
Inflammatory bowel disease (Crohn's disease and ulcerative colitis), multiple sc
CRD42020199697
Protocol for systematic review and meta-analysis on Randomized clinical trials (placebo-controlled or comparator) on the efficacy and safety of sphingosine-1-phosphotase receptor modulators (amiselimod, ozanimod, ponesimod, siponimod)
Subjects with any type/stage or multiple sclerosis; adult; using sphingosine-1-p
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Multiple Sclerosis
🏥 Names
Disease Name
Multiple Sclerosis
Alias Names
Multiple Sclerosis, Acute Fulminating; Multiple Sclerosis
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
MeSH Class
Immune System Diseases; Nervous System Diseases
DO Class
disease of anatomical entity
🔗 External References
🔍 Raw view — every non-empty column on this row (28 fields)
name
Multiple Sclerosis
alias name
Multiple Sclerosis, Acute Fulminating; Multiple Sclerosis
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
mesh disease class
Immune System Diseases; Nervous System Diseases
do disease class
disease of anatomical entity
umls disease type id
T047
mesh disease class id
C10; C20
do disease class id
DOID:7
herb disease id
HBDIS001992
disgenet id
C0026769
mesh id
D009103
do id
2377
icd10 id
G35
tcmsp disease id
529
🌿 Related Herbs
1 · contains this compound⚗️ Related Ingredients
8 · compounds in this herb🧬 Gene / Protein Targets
4 · genes implicated in this diseaseIFNG
Gene IFNG
MPO
Gene MPO
PPARG
Gene PPARG
Beta-2 adrenergic receptor
📋 Clinical Trials
12 · subject of clinical studyNCT00841321 Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
→ Multiple Sclerosis|Cognitive Ability, General
NCT00276341 Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment
→ Multiple Sclerosis, Relapsing-Remitting
NCT02280876 Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in
→ Multiple Sclerosis, Relapsing-Remitting
NCT03944447 Outcomes Mandate National Integration With Cannabis as Medicine
→ Chronic Pain|Chronic Pain Syndrome|Chronic Pain Du
NCT02898974 Medical Marijuana and Its Effects on Motor Function in People With Multiple Scle
→ Multiple Sclerosis
NCT01037088 Effects of Vaporized Marijuana on Neuropathic Pain
→ Neuropathic Pain|Reflex Sympathetic Dystrophy|Peri
NCT00248378 Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Scler
→ Multiple Sclerosis
NCT00754832 American Ginseng Treatment for Multiple Sclerosis Related Fatigue
→ Multiple Sclerosis
NCT04120675 Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary
→ Progressive Multiple Sclerosis
NCT02506751 Open-label Study of Liothyronine in MS
→ Multiple Sclerosis, Relapsing-Remitting|Multiple S
NCT01514370 Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclero
→ Multiple Sclerosis
NCT03740295 Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis
→ Multiple Sclerosis
📊 Meta-Analyses
12 · systematic reviewCRD42018105272 The incidence of adverse events of andrographis paniculata: a systematic review
→ - Diagnoses of upper respiratory tract infections
CRD42020172575 Protocol for a systematic review without meta-analysis of the safety of sphingos
→ Inflammatory bowel disease (Crohn's disease and ul
CRD42020199697 Protocol for systematic review and meta-analysis on Randomized clinical trials (
→ Subjects with any type/stage or multiple sclerosis
CRD42022367761 Intraocular Pressure Changes Following Glucosamine Use: A Meta-Analysis of Pre-P
→ The use of glucosamine has increased in recent dec
CRD42022363015 Myelin Oligodendrocyte Glycoprotein Antibody Disease Presenting Similar to Multi
→ Here, we will review cases of Myelin Oligodendrocy
CRD42016033054 The efficacy of inosine pranobex in non-HIV and non-cancer clinical conditions
→ Literature data concerning studies related to clin
CRD42016033054 The efficacy of inosine pranobex in non-HIV and non-cancer clinical conditions
→ Literature data concerning studies related to clin
CRD42017083037 Inosine for multiple sclerosis [Cochrane protocol]
→ The Cochrane Multiple Sclerosis and Rare Diseases
CRD42017083037 Inosine for multiple sclerosis [Cochrane protocol]
→ The Cochrane Multiple Sclerosis and Rare Diseases
CRD42016050246 Anti-inflammatory activity of melatonin in the treatment of multiple sclerosis:
→ Several studies have shown that melatonin reduces
CRD42022373972 Melatonin and melatonin receptor agonists for the treatment of sleep disturbance
→ The conditions under study are sleep-related behav
CRD42022360197 Efficacy and side effects of melatonin supplementation in patients with multiple
→ Multiple sclerosis: Multiple sclerosis (MS) is a c
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables